{"product_id":"association-for-molecular-pathology-annual-meeting-expo-2024","title":"Association for Molecular Pathology Annual Meeting \u0026 Expo 2024","description":"\u003ch3\u003eAssociation for Molecular Pathology Annual Meeting \u0026amp; Expo 2024\u003c\/h3\u003e\n\u003cstrong\u003e Include: 107 videos + 2 pdfs, size: 50.8 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: molecular pathologists, clinical laboratory directors, medical geneticists, oncologists, infectious disease specialists, researchers, and laboratory professionals\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cp data-end=\"572\" data-start=\"0\"\u003eThe Association for Molecular Pathology (AMP) Annual Meeting \u0026amp; Expo 2024 is the premier global gathering for professionals advancing the science and practice of molecular pathology. This year’s program delivers cutting-edge research, innovative technologies, and real-world clinical applications that are shaping the future of precision medicine. Featuring expert-led sessions, interactive workshops, and an extensive industry expo, the meeting provides a unique opportunity to stay ahead in the rapidly evolving landscape of molecular diagnostics.\u003c\/p\u003e\n\u003cp data-end=\"599\" data-start=\"574\"\u003e\u003cstrong data-end=\"597\" data-start=\"574\"\u003eWhat You Will Learn\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1007\" data-start=\"600\"\u003e\n\u003cli data-end=\"677\" data-start=\"600\"\u003e\n\u003cp data-end=\"677\" data-start=\"602\"\u003eBreakthroughs in molecular diagnostics, genomics, and biomarker discovery\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"761\" data-start=\"678\"\u003e\n\u003cp data-end=\"761\" data-start=\"680\"\u003eClinical applications in oncology, infectious diseases, and inherited disorders\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"842\" data-start=\"762\"\u003e\n\u003cp data-end=\"842\" data-start=\"764\"\u003eAdvances in next-generation sequencing, liquid biopsy, and digital pathology\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"923\" data-start=\"843\"\u003e\n\u003cp data-end=\"923\" data-start=\"845\"\u003eBest practices for integrating new molecular technologies into clinical care\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1007\" data-start=\"924\"\u003e\n\u003cp data-end=\"1007\" data-start=\"926\"\u003eUpdates on regulatory frameworks, reimbursement policies, and quality assurance\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1028\" data-start=\"1009\"\u003e\u003cstrong data-end=\"1026\" data-start=\"1009\"\u003eEvent Details\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1417\" data-start=\"1029\"\u003e\n\u003cli data-end=\"1106\" data-start=\"1029\"\u003e\n\u003cp data-end=\"1106\" data-start=\"1031\"\u003e\u003cstrong data-end=\"1041\" data-start=\"1031\"\u003eEvent:\u003c\/strong\u003e Association for Molecular Pathology Annual Meeting \u0026amp; Expo 2024\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1177\" data-start=\"1107\"\u003e\n\u003cp data-end=\"1177\" data-start=\"1109\"\u003e\u003cstrong data-end=\"1120\" data-start=\"1109\"\u003eFormat:\u003c\/strong\u003e In-person conference with hybrid participation options\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1294\" data-start=\"1178\"\u003e\n\u003cp data-end=\"1294\" data-start=\"1180\"\u003e\u003cstrong data-end=\"1203\" data-start=\"1180\"\u003eProgram Highlights:\u003c\/strong\u003e Keynote presentations, scientific sessions, poster discussions, and industry exhibitions\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1417\" data-start=\"1295\"\u003e\n\u003cp data-end=\"1417\" data-start=\"1297\"\u003e\u003cstrong data-end=\"1316\" data-start=\"1297\"\u003eTopics Covered:\u003c\/strong\u003e Emerging technologies, personalized medicine, diagnostic innovations, and bioinformatics solutions\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1737\" data-start=\"1419\"\u003e\u003cstrong data-end=\"1440\" data-start=\"1419\"\u003eWho Should Attend\u003c\/strong\u003e\u003cbr\u003eMolecular pathologists, clinical laboratory directors, medical geneticists, oncologists, infectious disease specialists, researchers, and laboratory professionals. It is also ideal for biotechnology and pharmaceutical professionals, regulatory specialists, and trainees in molecular medicine.\u003c\/p\u003e\n\u003cp data-end=\"2113\" data-is-last-node=\"\" data-is-only-node=\"\" data-start=\"1739\"\u003e\u003cstrong data-end=\"1753\" data-start=\"1739\"\u003eWhy Attend\u003c\/strong\u003e\u003cbr\u003eThis meeting is a must-attend for anyone seeking to deepen their expertise, explore the latest innovations, and connect with leaders in molecular pathology. Attendees will gain actionable insights, strengthen their professional network, and leave equipped to implement cutting-edge diagnostics and therapeutic strategies in clinical and research settings.\u003c\/p\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003ch2 data-end=\"162\" data-start=\"139\"\u003ePrograms \u0026amp; Schedules\u003c\/h2\u003e\n\u003cul data-end=\"229\" data-start=\"163\"\u003e\n\u003cli data-end=\"194\" data-start=\"163\"\u003e\n\u003cp data-end=\"194\" data-start=\"165\"\u003eAMP 2024 Workshop Program\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"229\" data-start=\"195\"\u003e\n\u003cp data-end=\"229\" data-start=\"197\"\u003eAMP On-Site Program Overview\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"258\" data-start=\"231\"\u003ePrecision Oncology \u0026amp; CGP\u003c\/h2\u003e\n\u003cul data-end=\"682\" data-start=\"259\"\u003e\n\u003cli data-end=\"338\" data-start=\"259\"\u003e\n\u003cp data-end=\"338\" data-start=\"261\"\u003eComprehensive Genomic Profiling (CGP) in Solid \u0026amp; Hematologic Malignancies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"387\" data-start=\"339\"\u003e\n\u003cp data-end=\"387\" data-start=\"341\"\u003eActionable Biomarkers in Early-Stage NSCLC\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"440\" data-start=\"388\"\u003e\n\u003cp data-end=\"440\" data-start=\"390\"\u003eBRAF Mutations in Metastatic Colorectal Cancer\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"492\" data-start=\"441\"\u003e\n\u003cp data-end=\"492\" data-start=\"443\"\u003eGene Fusion Detection Strategies for Oncology\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"553\" data-start=\"493\"\u003e\n\u003cp data-end=\"553\" data-start=\"495\"\u003eWhole Exome Sequencing in Solid Tumors—Clinical Impact\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"613\" data-start=\"554\"\u003e\n\u003cp data-end=\"613\" data-start=\"556\"\u003eRadiogenomics: Integrating Molecular and Imaging Data\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"682\" data-start=\"614\"\u003e\n\u003cp data-end=\"682\" data-start=\"616\"\u003eTumor Mutational Burden: Validation \u0026amp; Reporting (AMP\/CAP\/SITC)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"713\" data-start=\"684\"\u003eLiquid Biopsy, ctDNA \u0026amp; MRD\u003c\/h2\u003e\n\u003cul data-end=\"990\" data-start=\"714\"\u003e\n\u003cli data-end=\"776\" data-start=\"714\"\u003e\n\u003cp data-end=\"776\" data-start=\"716\"\u003ePan-Cancer Liquid Biopsy: Technologies \u0026amp; Early Detection\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"838\" data-start=\"777\"\u003e\n\u003cp data-end=\"838\" data-start=\"779\"\u003ectDNA Genotyping in NSCLC—Fast, Comprehensive Workflows\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"886\" data-start=\"839\"\u003e\n\u003cp data-end=\"886\" data-start=\"841\"\u003eMRD Testing in AML: Strategies \u0026amp; Pitfalls\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"937\" data-start=\"887\"\u003e\n\u003cp data-end=\"937\" data-start=\"889\"\u003eUltra-Sensitive MRD with Whole-Genome ppmSeq\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"990\" data-start=\"938\"\u003e\n\u003cp data-end=\"990\" data-start=\"940\"\u003eCell-Free DNA for MRD in Lymphoid Malignancies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"1021\" data-start=\"992\"\u003eNGS, PCR \u0026amp; Advanced Assays\u003c\/h2\u003e\n\u003cul data-end=\"1403\" data-start=\"1022\"\u003e\n\u003cli data-end=\"1081\" data-start=\"1022\"\u003e\n\u003cp data-end=\"1081\" data-start=\"1024\"\u003eNGS Implementation Journeys: Hospital \u0026amp; Academic Labs\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1131\" data-start=\"1082\"\u003e\n\u003cp data-end=\"1131\" data-start=\"1084\"\u003eRapid NGS for Myeloid\/Lymphoid Malignancies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1182\" data-start=\"1132\"\u003e\n\u003cp data-end=\"1182\" data-start=\"1134\"\u003eAmplicon-Based NGS: End-to-End CGP Solutions\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1235\" data-start=\"1183\"\u003e\n\u003cp data-end=\"1235\" data-start=\"1185\"\u003e32-Target Multiplex RT-PCR in 10 Minutes (POC)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1297\" data-start=\"1236\"\u003e\n\u003cp data-end=\"1297\" data-start=\"1238\"\u003eDroplet Digital PCR (ddPCR) in Precision Oncology \u0026amp; MRD\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1356\" data-start=\"1298\"\u003e\n\u003cp data-end=\"1356\" data-start=\"1300\"\u003eLong-Range PCR + Long-Read Sequencing for Hard Genes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1403\" data-start=\"1357\"\u003e\n\u003cp data-end=\"1403\" data-start=\"1359\"\u003eqPCR Exosome Workflows for ESR1 \u0026amp; Beyond\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"1443\" data-start=\"1405\"\u003eStructural Genomics \u0026amp; Spatial Omics\u003c\/h2\u003e\n\u003cul data-end=\"1690\" data-start=\"1444\"\u003e\n\u003cli data-end=\"1510\" data-start=\"1444\"\u003e\n\u003cp data-end=\"1510\" data-start=\"1446\"\u003eOptical Genome Mapping (OGM) in Leukemia, Lymphoma \u0026amp; Sarcoma\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1567\" data-start=\"1511\"\u003e\n\u003cp data-end=\"1567\" data-start=\"1513\"\u003eOGM + Long-Read Sequencing for Structural Variants\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1632\" data-start=\"1568\"\u003e\n\u003cp data-end=\"1632\" data-start=\"1570\"\u003eHigh-Throughput Spatial Multiomics for Biomarker Discovery\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1690\" data-start=\"1633\"\u003e\n\u003cp data-end=\"1690\" data-start=\"1635\"\u003eHighly Multiplexed Spatial Transcriptomics in NSCLC\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"1717\" data-start=\"1692\"\u003ePharmacogenomics (PGx)\u003c\/h2\u003e\n\u003cul data-end=\"1938\" data-start=\"1718\"\u003e\n\u003cli data-end=\"1767\" data-start=\"1718\"\u003e\n\u003cp data-end=\"1767\" data-start=\"1720\"\u003eGuideline-Driven PGx Testing (AMP Tier 1–2)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1816\" data-start=\"1768\"\u003e\n\u003cp data-end=\"1816\" data-start=\"1770\"\u003eEnterprise-Wide PGx: Practical Integration\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1857\" data-start=\"1817\"\u003e\n\u003cp data-end=\"1857\" data-start=\"1819\"\u003ePharmacists’ Roles in Clinical PGx\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1938\" data-start=\"1858\"\u003e\n\u003cp data-end=\"1938\" data-start=\"1860\"\u003eGlobal PGx Recommendations (AMP\/ACMG\/CPIC\/CAP\/DPWG\/ESPT\/PharmGKB\/PharmVar)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"1962\" data-start=\"1940\"\u003eBreast Cancer Focus\u003c\/h2\u003e\n\u003cul data-end=\"2134\" data-start=\"1963\"\u003e\n\u003cli data-end=\"2029\" data-start=\"1963\"\u003e\n\u003cp data-end=\"2029\" data-start=\"1965\"\u003eESR1 Mutations \u0026amp; ctDNA in Metastatic HR+\/HER2- Breast Cancer\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2075\" data-start=\"2030\"\u003e\n\u003cp data-end=\"2075\" data-start=\"2032\"\u003ePIK3CA, AKT1, PTEN in HR+\/HER2- Disease\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2134\" data-start=\"2076\"\u003e\n\u003cp data-end=\"2134\" data-start=\"2078\"\u003e4-Gene Methylation Panel to Expand PARPi Eligibility\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"2170\" data-start=\"2136\"\u003eLab Operations, QA \u0026amp; Compliance\u003c\/h2\u003e\n\u003cul data-end=\"2635\" data-start=\"2171\"\u003e\n\u003cli data-end=\"2225\" data-start=\"2171\"\u003e\n\u003cp data-end=\"2225\" data-start=\"2173\"\u003eLaboratory Automation: Implementation Essentials\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2290\" data-start=\"2226\"\u003e\n\u003cp data-end=\"2290\" data-start=\"2228\"\u003eOptimizing Clinical Lab Operations \u0026amp; Testing Consolidation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2349\" data-start=\"2291\"\u003e\n\u003cp data-end=\"2349\" data-start=\"2293\"\u003eAssay Development for RNA Targets—Performance \u0026amp; Cost\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2403\" data-start=\"2350\"\u003e\n\u003cp data-end=\"2403\" data-start=\"2352\"\u003eQC Perfection: Patient-Like Controls \u0026amp; Accuracy\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2458\" data-start=\"2404\"\u003e\n\u003cp data-end=\"2458\" data-start=\"2406\"\u003eEnterprise CGP\/HRD Automation (AVENIO Workflows)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2518\" data-start=\"2459\"\u003e\n\u003cp data-end=\"2518\" data-start=\"2461\"\u003eValue of Internalizing FDA-Authorized Tumor Profiling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2576\" data-start=\"2519\"\u003e\n\u003cp data-end=\"2576\" data-start=\"2521\"\u003eLDT Compliance in an Uncertain Regulatory Landscape\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2635\" data-start=\"2577\"\u003e\n\u003cp data-end=\"2635\" data-start=\"2579\"\u003eAMP Lawsuit vs FDA: Oversight of Lab-Developed Tests\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"2665\" data-start=\"2637\"\u003eBioinformatics, AI \u0026amp; Data\u003c\/h2\u003e\n\u003cul data-end=\"2955\" data-start=\"2666\"\u003e\n\u003cli data-end=\"2715\" data-start=\"2666\"\u003e\n\u003cp data-end=\"2715\" data-start=\"2668\"\u003eClinical Bioinformatician Body of Knowledge\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2757\" data-start=\"2716\"\u003e\n\u003cp data-end=\"2757\" data-start=\"2718\"\u003eDeep Learning in Precision Medicine\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2806\" data-start=\"2758\"\u003e\n\u003cp data-end=\"2806\" data-start=\"2760\"\u003eLLMs in Healthcare: Language of Innovation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2854\" data-start=\"2807\"\u003e\n\u003cp data-end=\"2854\" data-start=\"2809\"\u003eStandardization Efforts for AI in the Lab\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2902\" data-start=\"2855\"\u003e\n\u003cp data-end=\"2902\" data-start=\"2857\"\u003eOpen-Source Tools for Molecular Pathology\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2955\" data-start=\"2903\"\u003e\n\u003cp data-end=\"2955\" data-start=\"2905\"\u003enavify \u0026amp; Tertiary Analysis for CGP + HRD Score\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"2994\" data-start=\"2957\"\u003eInfectious Disease \u0026amp; Public Health\u003c\/h2\u003e\n\u003cul data-end=\"3330\" data-start=\"2995\"\u003e\n\u003cli data-end=\"3046\" data-start=\"2995\"\u003e\n\u003cp data-end=\"3046\" data-start=\"2997\"\u003eNext-Gen Mycology: Molecular Testing Advances\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3106\" data-start=\"3047\"\u003e\n\u003cp data-end=\"3106\" data-start=\"3049\"\u003eInfectious Disease Diagnostics—From Gram Stain to NGS\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3153\" data-start=\"3107\"\u003e\n\u003cp data-end=\"3153\" data-start=\"3109\"\u003eSyndromic Panels for Infectious Diseases\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3228\" data-start=\"3154\"\u003e\n\u003cp data-end=\"3228\" data-start=\"3156\"\u003eParasitology in the 21st Century: NAATs for Detection \u0026amp; Surveillance\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3276\" data-start=\"3229\"\u003e\n\u003cp data-end=\"3276\" data-start=\"3231\"\u003eMolecular at Home \u0026amp; Point-of-Care Testing\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3330\" data-start=\"3277\"\u003e\n\u003cp data-end=\"3330\" data-start=\"3279\"\u003eViral Associations in Human Cancer via Genomics\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"3370\" data-start=\"3332\"\u003eHematopathology \u0026amp; Myeloid\/Neoplasms\u003c\/h2\u003e\n\u003cul data-end=\"3504\" data-start=\"3371\"\u003e\n\u003cli data-end=\"3409\" data-start=\"3371\"\u003e\n\u003cp data-end=\"3409\" data-start=\"3373\"\u003eCGP Utility in Myeloid Neoplasms\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3452\" data-start=\"3410\"\u003e\n\u003cp data-end=\"3452\" data-start=\"3412\"\u003eFLT3-ITD \u0026amp; NPM1 MRD by Sensitive NGS\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3504\" data-start=\"3453\"\u003e\n\u003cp data-end=\"3504\" data-start=\"3455\"\u003eNew Molecular Discoveries in B-Cell Neoplasms\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"3548\" data-start=\"3506\"\u003eLung Cancer Guidelines \u0026amp; Best Practices\u003c\/h2\u003e\n\u003cul data-end=\"3752\" data-start=\"3549\"\u003e\n\u003cli data-end=\"3632\" data-start=\"3549\"\u003e\n\u003cp data-end=\"3632\" data-start=\"3551\"\u003e2024 CAP\/IASLC\/AMP Update: Molecular Testing for TKI Selection in Lung Cancer\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3694\" data-start=\"3633\"\u003e\n\u003cp data-end=\"3694\" data-start=\"3635\"\u003eDifficult NSCLC Samples: Fast, Cost-Effective Profiling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3752\" data-start=\"3695\"\u003e\n\u003cp data-end=\"3752\" data-start=\"3697\"\u003ectDNA \u0026amp; Ultra-Fast NGS at Diagnosis and Progression\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"3788\" data-start=\"3754\"\u003eWomen’s Health, Equity \u0026amp; Ethics\u003c\/h2\u003e\n\u003cul data-end=\"3969\" data-start=\"3789\"\u003e\n\u003cli data-end=\"3842\" data-start=\"3789\"\u003e\n\u003cp data-end=\"3842\" data-start=\"3791\"\u003eDisparities in Genetic Testing: Closing the Gap\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3897\" data-start=\"3843\"\u003e\n\u003cp data-end=\"3897\" data-start=\"3845\"\u003eRole of Gender Identification in Genetic Testing\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3969\" data-start=\"3898\"\u003e\n\u003cp data-end=\"3969\" data-start=\"3900\"\u003eBiobanking: From Pathology to Repository—Data \u0026amp; Sample Governance\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"4005\" data-start=\"3971\"\u003eTraining, Education \u0026amp; Community\u003c\/h2\u003e\n\u003cul data-end=\"4410\" data-start=\"4006\"\u003e\n\u003cli data-end=\"4073\" data-start=\"4006\"\u003e\n\u003cp data-end=\"4073\" data-start=\"4008\"\u003eCurated Resources for Training in Molecular Pathology (EdCop)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4111\" data-start=\"4074\"\u003e\n\u003cp data-end=\"4111\" data-start=\"4076\"\u003eTechnologist Innovation Session\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4207\" data-start=\"4112\"\u003e\n\u003cp data-end=\"4207\" data-start=\"4114\"\u003eSelected Platform Presentations (Genetics, Informatics, Tech, HemePath, ID, Solid Tumors)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4269\" data-start=\"4208\"\u003e\n\u003cp data-end=\"4269\" data-start=\"4210\"\u003eEAC Town Hall: 2024 Activities \u0026amp; Legislative Priorities\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4336\" data-start=\"4270\"\u003e\n\u003cp data-end=\"4336\" data-start=\"4272\"\u003eSlice Testing: Ordering to Reporting—CAP\/NSGC Considerations\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4410\" data-start=\"4337\"\u003e\n\u003cp data-end=\"4410\" data-start=\"4339\"\u003eCase Studies: Genetics, HemePath, Solid Tumors, Infectious Diseases\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954499194978,"sku":"MED-AMB04692","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Association-for-Molecular-Pathology-Annual-Meeting-Expo-2024.jpg?v=1779378149","url":"https:\/\/meducourse.com\/products\/association-for-molecular-pathology-annual-meeting-expo-2024","provider":"Meducourse","version":"1.0","type":"link"}